Foghorn Therapeutics Inc.
US ˙ NasdaqGM ˙ US3441741077

SecurityFHTX / Foghorn Therapeutics Inc.
InstitutionPoint72 Asset Management, L.P.
ManagerSteven Cohen
Latest Disclosed Ownership27,646 shares
Latest Disclosed Value $ 132,148
Point72 Asset Management, L.P. reports 55.39% decrease in ownership of FHTX / Foghorn Therapeutics Inc.

On May 15, 2026 - Point72 Asset Management, L.P. filed a 13F-HR form disclosing ownership of 27,646 shares of Foghorn Therapeutics Inc. (US:FHTX) valued at $132,148 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 61,968 shares of Foghorn Therapeutics Inc.. This represents a change in shares of -55.39% during the quarter. The current value of the position is $103,120 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F FOGHORN THERAPEUTICS COM 344174107 27,646 -34,322 -55.39 132 -60.48 0.0002
2026-02-17 2025-12-31 13F FOGHORN THERAPEUTICS COM 344174107 61,968 -309,065 -83.30 335 -81.59 0.0004
2025-11-14 2025-09-30 13F FOGHORN THERAPEUTICS COM 344174107 371,033 -297,686 -44.52 1,814 -42.27 0.0030
2025-08-14 2025-06-30 13F FOGHORN THERAPEUTICS COM 344174107 668,719 43,502 6.96 3,143 37.69 0.0062
2025-07-21 2025-03-31 13F/A-1 FOGHORN THERAPEUTICS COM 344174107 625,217 -9,544 -1.50 2,282 -23.83 0.0052
2025-05-15 2025-03-31 13F FOGHORN THERAPEUTICS COM 344174107 625,217 -9,544 2,282 0.0052
2025-02-14 2024-12-31 13F FOGHORN THERAPEUTICS COM 344174107 634,761 235,059 58.81 2,996 -19.48 0.0066
2024-11-14 2024-09-30 13F FOGHORN THERAPEUTICS COM 344174107 399,702 -6,939 -1.71 3,721 59.15 0.0095
2024-09-16 2024-06-30 13F/A-2 FOGHORN THERAPEUTICS COM 344174107 406,641 -30,728 -7.03 2,338 -20.31 0.0061
2024-08-19 2024-06-30 13F/A-1 FOGHORN THERAPEUTICS COM 344174107 406,641 -30,728 2,338 0.0061
2024-08-14 2024-06-30 13F FOGHORN THERAPEUTICS COM 344174107 406,641 -30,728 2,338 0.0061
2024-05-15 2024-03-31 13F FOGHORN THERAPEUTICS COM 344174107 437,369 -102,631 -19.01 2,935 -15.76 0.0071
2024-02-14 2023-12-31 13F FOGHORN THERAPEUTICS COM 344174107 540,000 255,145 89.57 3,483 144.59 0.0084
2023-11-14 2023-09-30 13F FOGHORN THERAPEUTICS COM 344174107 284,855 5,700 2.04 1,424 -27.53 0.0042
2023-08-14 2023-06-30 13F FOGHORN THERAPEUTICS COM 344174107 279,155 279,155 1,965 0.0058
2023-05-15 2023-03-31 13F FOGHORN THERAPEUTICS COM 344174107 0 -33,000 -100.00 0 -100.00
2023-05-15 2022-12-31 13F/A-1 FOGHORN THERAPEUTICS COM 344174107 33,000 -355,600 -91.51 211 -93.70 0.0007
2023-02-14 2022-12-31 13F FOGHORN THERAPEUTICS COM 344174107 33,000 -355,600 211 0.0007
2022-11-14 2022-09-30 13F FOGHORN THERAPEUTICS COM 344174107 388,600 12,600 3.35 3,334 -34.81 0.0133
2022-08-15 2022-06-30 13F FOGHORN THERAPEUTICS COM 344174107 376,000 370,800 7,130.77 5,114 6,373.42 0.0216
2022-05-16 2022-03-31 13F FOGHORN THERAPEUTICS COM 344174107 5,200 -378,272 -98.64 79 -99.10 0.0003
2022-02-14 2021-12-31 13F FOGHORN THERAPEUTICS COM 344174107 383,472 383,472 8,770 0.0350
2021-08-16 2021-06-30 13F FOGHORN THERAPEUTICS COM 344174107 0 -109,200 -100.00 0 -100.00
2021-05-17 2021-03-31 13F FOGHORN THERAPEUTICS COM 344174107 109,200 109,200 1,439 0.0067
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.